Cargando…
COVID‐19 diagnostic testing: Technology perspective
The corona virus disease 2019 (COVID‐19) is a highly contagious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). More than 18 million people were infected with a total of 0.7 million deaths in ∼188 countries. Controlling the spread of SARS‐CoV‐2 is therefore inhere...
Autores principales: | Xu, Meng, Wang, Dan, Wang, Hongye, Zhang, Xiaomei, Liang, Te, Dai, Jiayu, Li, Meng, Zhang, Jiahui, Zhang, Kai, Xu, Danke, Yu, Xiaobo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443140/ https://www.ncbi.nlm.nih.gov/pubmed/32898340 http://dx.doi.org/10.1002/ctm2.158 |
Ejemplares similares
-
Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection
por: Hou, Xin, et al.
Publicado: (2020) -
Down‐regulation of SARS‐CoV‐2 neutralizing antibodies in vaccinated smokers
por: Zhang, Jiahui, et al.
Publicado: (2022) -
SARS-CoV-2 Proteome Microarray for Mapping
COVID-19 Antibody Interactions at Amino Acid Resolution
por: Wang, Hongye, et al.
Publicado: (2020) -
Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients
por: Cheng, Linlin, et al.
Publicado: (2021) -
In-Depth Serum Proteomics Reveals the Trajectory of Hallmarks of Cancer in Hepatitis B Virus–Related Liver Diseases
por: Xu, Meng, et al.
Publicado: (2023)